VNDA insider buying
1 cluster buyVanda Pharmaceuticals Inc. · Healthcare
When two or more insiders at Vanda Pharmaceuticals Inc. buy VNDA on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in VNDA plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.
Detected clusters
- Feb 21 – Aug 7, 2025Detected Aug 7, 2025High conviction2 insidersTotal bought$513.6KMarket cap$374.6M
All notable open-market buys in VNDA
Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.
| Date | Insider | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Aug 7, 2025 | Director, President and CEO, Chairman of the Board | 10,000 | $4.15 | $41.5K | SEC ↗ |
| May 21, 2025 | Director, President and CEO, Chairman of the Board | 9,519 | $4.40 | $41.9K | SEC ↗ |
| May 21, 2025 | Director, President and CEO, Chairman of the Board | 481 | $4.39 | $2.1K | SEC ↗ |
| May 16, 2025 | Director, President and CEO, Chairman of the Board | 20,000 | $4.22 | $84.4K | SEC ↗ |
| Mar 6, 2025 | Director, President and CEO, Chairman of the Board | 5,000 | $5.02 | $25.1K | SEC ↗ |
| Mar 6, 2025 | Director, President and CEO, Chairman of the Board | 5,000 | $5.01 | $25.1K | SEC ↗ |
| Mar 5, 2025 | Director, President and CEO, Chairman of the Board | 5,000 | $5.03 | $25.2K | SEC ↗ |
| Mar 5, 2025 | Director, President and CEO, Chairman of the Board | 5,000 | $5.01 | $25.1K | SEC ↗ |
| Mar 3, 2025 | Director, President and CEO, Chairman of the Board | 10,000 | $4.71 | $47.1K | SEC ↗ |
| Feb 28, 2025 | Director, President and CEO, Chairman of the Board | 10,000 | $4.76 | $47.6K | SEC ↗ |
| Feb 27, 2025 | Director, President and CEO, Chairman of the Board | 10,000 | $4.76 | $47.6K | SEC ↗ |
| Feb 26, 2025 | Director, President and CEO, Chairman of the Board | 5,000 | $4.78 | $23.9K | SEC ↗ |
| Feb 26, 2025 | Director, President and CEO, Chairman of the Board | 5,000 | $4.75 | $23.8K | SEC ↗ |
| Feb 25, 2025 | Director, President and CEO, Chairman of the Board | 10,000 | $4.46 | $44.6K | SEC ↗ |
| Feb 21, 2025 | Moran Kevin Patrickcluster SVP, CFO & Treasurer | 2,000 | $4.39 | $8.8K | SEC ↗ |
More Healthcare stocks with insider cluster buys
VNDA insider buying — FAQ
- Are insiders buying VNDA stock?
- Yes — 2 distinct insiders have bought VNDA (Vanda Pharmaceuticals Inc.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Aug 8, 2025.
- How much VNDA stock have insiders bought?
- Insiders have bought a combined $513.6K of VNDA across 15 open-market purchases, based on SEC Form 4 filings.
- What is an insider cluster buy in VNDA?
- A cluster buy is two or more distinct Vanda Pharmaceuticals Inc. insiders — officers, directors, or 10% owners — each buying VNDA on the open market within a rolling window. VNDA has 1 detected cluster buy to date.
- Where does this VNDA insider trading data come from?
- Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.
How we track insider buying in VNDA
We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy VNDA within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?
This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding VNDA.